Rhumbline Advisers Generation Bio Co. Transaction History

Rhumbline Advisers

$109 Billion
Q4 2024

A detailed history of Rhumbline Advisers transactions in Generation Bio Co. stock. As of the latest transaction made, Rhumbline Advisers holds 73,445 shares of GBIO stock, worth $63,162. This represents 0.0% of its overall portfolio holdings.

Number of Shares

73,445

Previous 75,619 2.87%

Holding current value

$63,162

Previous $186,000 58.6%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	SELL	$1.02 - $2.51 $2,217 - $5,456	-2,174 Reduced 2.87%	73,445 $77,000
Q3 2024 Nov 12, 2024	SELL	$2.16 - $3.51 $7,093 - $11,526	-3,284 Reduced 4.16%	75,619 $186,000
Q2 2024 Aug 01, 2024	BUY	$2.64 - $4.35 $14,335 - $23,620	5,430 Added 7.39%	78,903 $222,000
Q1 2024 May 09, 2024	BUY	$1.73 - $4.07 $2,774 - $6,528	1,604 Added 2.23%	73,473 $299,000
Q4 2023 Feb 08, 2024	BUY	$0.91 - $3.35 $447 - $1,648	492 Added 0.69%	71,869 $118,000
Q3 2023 Nov 09, 2023	SELL	$3.65 - $6.9 $186 - $351	-51 Reduced 0.07%	71,377 $270,000
Q2 2023 Aug 08, 2023	SELL	$3.5 - $5.67 $12,194 - $19,754	-3,484 Reduced 4.65%	71,428 $392,000
Q1 2023 May 11, 2023	BUY	$3.61 - $7.01 $2,097 - $4,072	581 Added 0.78%	74,912 $322,000
Q4 2022 Feb 14, 2023	BUY	$3.66 - $6.77 $13,428 - $24,839	3,669 Added 5.19%	74,331 $292,000
Q3 2022 Nov 10, 2022	BUY	$4.68 - $8.34 $27,541 - $49,080	5,885 Added 9.09%	70,662 $375,000
Q2 2022 Aug 11, 2022	BUY	$4.87 - $9.41 $100,424 - $194,043	20,621 Added 46.7%	64,777 $425,000
Q1 2022 May 12, 2022	BUY	$4.16 - $7.76 $1,160 - $2,165	279 Added 0.64%	44,156 $324,000
Q4 2021 Feb 10, 2022	SELL	$5.99 - $24.97 $7,355 - $30,663	-1,228 Reduced 2.72%	43,877 $311,000
Q3 2021 Nov 12, 2021	BUY	$20.0 - $27.43 $39,400 - $54,037	1,970 Added 4.57%	45,105 $1.13 Million
Q2 2021 Aug 05, 2021	BUY	$24.34 - $38.34 $22,879 - $36,039	940 Added 2.23%	43,135 $1.16 Million
Q1 2021 May 06, 2021	BUY	$24.74 - $40.2 $704,966 - $1.15 Million	28,495 Added 207.99%	42,195 $1.2 Million
Q4 2020 Feb 10, 2021	BUY	$21.68 - $51.61 $53,506 - $127,373	2,468 Added 21.97%	13,700 $388,000
Q3 2020 Nov 12, 2020	BUY	$18.07 - $31.84 $202,962 - $357,626	11,232 New	11,232 $347,000

Others Institutions Holding GBIO

# of Institutions

Shares Held

49.6M

Call Options Held

Put Options Held

View Full List

About Generation Bio Co.

Ticker GBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,011,200
Market Cap $50.7M
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...

More about GBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Generation Bio Co. Transaction History